first edition (1980) of the Orange Book - FDA Law Blog

More documents

Recommendations

Info

APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST124SOYBEAN OILINJECTABLE; INJECTIONINTRA LIPID lOY.CUTTER LABSSPECTINOMYCIN HYDROCHLORIDElOY.INJECTABLE; INJECTIONTROBICINUPJOHN E~ 2GM BASE/VIAL * E~ 4GM BASE/VIALSPIRONOLACTONETABLET; ORALALDACTOMEAB SEARLESPJ:ROHOLACTOHEAB .BOLAR PHARMAB CORD LABSAB ZENITH LABS25MG25MG2SMG2SMGSPIRONO.LACTONE; *MULTIPLE*SEE HYDROCHLOROTHIAZIDE; SPIRONOLACTONESTREPTOMYCIN SULFATEINJECTABLE; INJECTIONSTREPTOMYCJ:H SULFATEAP ELI LILLYAPAP JOHN D COPANOSAP PFIZER LABSAPSUCCINYLCHOLINE CHLORIDEE9 lGM BASE/2ML * E9 lGM BASE/VJ:AL *E9 SGM BASE/VJ:ALE9 SCCMS BASE/MLE9 lSM BASE/2ML * E9 lSM BASE/VJ:AL *E9 SSM BASE/VJ:ALINJECTABLE; INJECTIONAHECTJ:HEAP BURROUGHS WELLCOME 20MG/ML * SOMG/ML500MG/AMP * lGM/AMPSUCCINYLCHOLINE CHLORIDEAPINJECTABLE; INJECTIONQUELZCZHABBOTT LABS 20MG/ML * SOMG/ML * 100MG/MLSUCCZHYLCHOLZHE CHLORZDEAP ORGANON/AKZONA 20MG/MLTRAVENOL LABS 500MG/VIAL * lGM/VIALSUCOSTRZHAP ER S~UIBB AND SONS 20MG/ML * SOMG/ML * 100MG/MLSULFABENZAMIDE; SULFACETAMIDE; SULFATHIAZOLETABLET; VAGINALSULTRINORTHO PHARMl84MG;143.75MG;172.5MGSULFABENZAMIDE; SULFACETAMIDE; SULFATHIAZOLE; UREACREAM; VAGINALSULTRJ:HAT ORTHO PHARMTRJ:PLE SULFAAT BYK-GULDENSULFACETAMIDE SODIUMOINTMENT; OPHTHALMICBLEFH-10AT ALLERGAN PHARMSCETAMZDE10%AT ALCON LABSSODIUM SULAMYD10%AT SCHERINGSULFACETAMZDE SODIUMlOr.AT E FOUGERA/BYK-GULDEN 10%SOLUTION/DROPS; OPHTHALMICBLEPH-10AT ALLERGAN PHARMS lOr.BLEPH-30AT ALLERGAN PHARMS 30%ISOPTO CETAMIDEAT ALCON LABS lS%3.77.;2.86%;3.42%;0.64%3.77.;2.86%;3.42%;0.64%
APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST125SULFACETAMIDE SODIUMSOLUTION/DROPS; OPHTHALMICSODJ:UM SULAMYDAT SCHERING 10? IE 30?SODJ:UM SULFACETAMJ:OEAT BARNES-HIND PHARMS 10? IE 30?AT KETCHUtl LABS 10? IE 30XAT MAURRY BIOLOGICAL 10? IE 15? IE 30?SULF"10AT SMITH MILLER PATCH 10?SULFACEL-1-5-AT STERI-MED/KETCHUM 15?SULFACETAMIDE; *MUL TIPLE*SEE SULFABENZAMIDE; SULFACETAMIDE; SULFATHIAZOLE; UREASEE SULFABENZAMIDE; SULFACETAMIDE; SULFATHIAZOLESULFACHLORPYRIDAZINETABLET; ORALSONILYNWALLACE LABS/C-WSULFACYTINETABLET; ORAtRENOQUIDPARKE-DAVIS/W-LSULFADIAZINESOOMG2S0MGTABLET; ORALSULFADJ:AZJ:HEABBOTT LABS300MGAD ELI LILLY 500MGAB LANNETT 500MGAB LEDERLE LABS/AM CYAN 500MGAB RICHLYN LABS ~AD STAN LABS PHARM 500MGSULFADIAZINE SODIUMINJECTABLE; INJECTIONSULFADIAZINE SODIUMLEDERLE LABS/AM CYAN 2S0MG/MLSULFADIAZINE; SULFAMERAZINESUSPENSION; ORALSULFONAMIDES DUPLEXELI LILLYSULFAMERAZINE; *MULTIPLE*SEE SULFADIAZINE; SULFAMERAZINEADADSULFAMETERTABLET; ORALSULLAAH ROBINSSULFAMETHIZOLESUSPENSION; ORALPROKLAROJF #2/CHROMALLOYTABLET; ORALMICROSULOJF #2/CHROMALLOYPROKLAROJF #2/CHROMALLOYTHJ:OSULFJ:LAYERST LABS/AMHOSULFAMETHOXAZOLESUSPENSION; ORALGANTANOLHOFFMANN-LA ROCHE2S0MG/SML;2S0MG/SMLSOOMGSOOMG/SMLIGMSOOMGSOOMG2S0MGSOOMG/SML
Page 5:
RXD AND DRUG ACMINISTRATIONAPProVED
Page 9:
approved application, a list of app
Page 12 and 13:
products that have been approved" i
Page 14 and 15:
To assist the user in relating the
Page 16 and 17:
an evaluatien of therapeutic equiva
Page 18 and 19:
ioavailability data is required for
Page 20 and 21:
B - Drug products that FDA does not
Page 22 and 23:
and the rate of absorption.pharmace
Page 24 and 25:
4. Erythromycin stearate Tablets -
Page 27 and 28:
II. LISTINGSA. FORMAT GUIDEThis p..
Page 29 and 30:
CURRENT STATUS - POSSIBLY EFFECTIVE
Page 31 and 32:
DRUG ProDUCT EKAMPLESSingle Ingredi
Page 33 and 34:
APPROVED PRESCRIPTION DRUG PRODUCTS
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
j./APPROVED PRESCRIPTION DRUG PRODU
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
-,----APPROVED PRESCRIPTION DRUG PR
Page 67 and 68:
APPROVED PRESCRI~TIOHDRUG PRODUCTSD
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
DIMENHYDlHNATEAPPROVED PRESCRIPTION
Page 79 and 80:
Page 81 and 82:
------"".,APPROVED PRESCRIPTION DRU
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
APPROVED ¥RESCRIPTION DRUG PRODUCT
Page 93 and 94:
Page 95 and 96:
'''"APPROVED PRESCRIPTION DRUG PROD
Page 97 and 98:
----..//APPROVED PRESCRIPTION DRUG
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 125 and 126: "~''''''-- .APPROVED PRESCRIPTION D
Page 155: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 189 and 190: PERCORTEN PIVALATE, DESOXYCORTICOST
Page 195: oAPPROVED PRESCRIPTION DRUG PRODUCT
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
APPROVED PRESCRIPTIOH DRUG PRODUCTS
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243:
Page 246 and 247:
PRESCRIPTION DRUG PRODUCTS DEEMED A
Page 248 and 249:
Page 250 and 251:
show all

first edition (1980) of the Orange Book - FDA Law Blog

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?